These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 36652429)
1. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study. Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429 [TBL] [Abstract][Full Text] [Related]
3. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection. Kim MM; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Wu CL; Dahl DM J Urol; 2022 Jan; 207(1):86-94. PubMed ID: 34428921 [TBL] [Abstract][Full Text] [Related]
4. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies. Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932 [TBL] [Abstract][Full Text] [Related]
5. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy. Hansen NL; Kesch C; Barrett T; Koo B; Radtke JP; Bonekamp D; Schlemmer HP; Warren AY; Wieczorek K; Hohenfellner M; Kastner C; Hadaschik B BJU Int; 2017 Nov; 120(5):631-638. PubMed ID: 27862869 [TBL] [Abstract][Full Text] [Related]
6. Transperineal versus Transrectal MRI/TRUS fusion-guided prostate biopsy in a large, ethnically diverse, and multiracial cohort. Ramacciotti LS; Strauss D; Cei F; Kaneko M; Mokhtar D; Cai J; Jadvar D; Cacciamani GE; Aron M; Halteh PB; Duddalwar V; Gill I; Abreu AL Int Braz J Urol; 2024; 50(5):616-628. PubMed ID: 39106117 [TBL] [Abstract][Full Text] [Related]
7. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway. Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer. Lughezzani G; Saita A; Lazzeri M; Paciotti M; Maffei D; Lista G; Hurle R; Buffi NM; Guazzoni G; Casale P Eur Urol Oncol; 2019 May; 2(3):329-332. PubMed ID: 31200848 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer. Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099 [TBL] [Abstract][Full Text] [Related]
10. Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association. Koparal MY; Sözen TS; Karşıyakalı N; Aslan G; Akdoğan B; Şahin B; Türkeri L; Prostate; 2022 Mar; 82(4):425-432. PubMed ID: 34927740 [TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy. Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy. Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121 [TBL] [Abstract][Full Text] [Related]
13. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Ploussard G; Barret E; Fiard G; Lenfant L; Malavaud B; Giannarini G; Almeras C; Aziza R; Renard-Penna R; Descotes JL; Rozet F; Beauval JB; Salin A; Rouprêt M Eur Urol Oncol; 2024 Oct; 7(5):1080-1087. PubMed ID: 38403523 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate. Oberlin DT; Casalino DD; Miller FH; Matulewicz RS; Perry KT; Nadler RB; Kundu S; Catalona WJ; Meeks JJ Urology; 2016 Jun; 92():75-9. PubMed ID: 26966043 [TBL] [Abstract][Full Text] [Related]
15. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210 [TBL] [Abstract][Full Text] [Related]
16. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Kaneko M; Medina LG; Lenon MSL; Hemal S; Sayegh AS; Jadvar DS; Ramacciotti LS; Paralkar D; Cacciamani GE; Lebastchi AH; Salhia B; Aron M; Hopstone M; Duddalwar V; Palmer SL; Gill IS; Abreu AL Sci Rep; 2023 Aug; 13(1):13457. PubMed ID: 37596374 [TBL] [Abstract][Full Text] [Related]
18. Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study. Pham THN; Schulze-Hagen MF; Rahnama'i MS Cancer Rep (Hoboken); 2024 Feb; 7(2):e1962. PubMed ID: 38217298 [TBL] [Abstract][Full Text] [Related]
19. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
20. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]